Pricing Log in Create free account

Inhibrx Biosciences, Inc. (INBX) vs Vor Biopharma Inc. (VOR)

Inhibrx Biosciences, Inc. and Vor Biopharma Inc. are both Biotechnology companies. Inhibrx Biosciences, Inc. and Vor Biopharma Inc. are of similar size ($1.2B and $1.2B). Across the 9 metrics below, Inhibrx Biosciences, Inc. leads on 5 and Vor Biopharma Inc. on 4.

Valuation

Metric INBX VOR Biotechnology median
P/E n/m n/m 10.60
P/S 424.97 n/m 9.40
P/B n/m 0.38 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.50 0.66
EV/Sales 438.60 n/m 9.02
Earnings yield (10.39%) (1,910.79%) (32.88%)
Free cash flow yield (9.85%) (141.07%) (23.13%)

Profitability

Metric INBX VOR Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,773.60%) (69.27%) (51.96%)
Return on assets (75.44%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INBX VOR Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (108.03%) (107.35%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric INBX VOR Biotechnology median
Debt to equity (3.33) 0.21 0.00
Current ratio 5.07 10.69 4.97
Net debt to EBITDA 0.18 2.27 1.01

Dividend

Metric INBX VOR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INBX VOR Biotechnology median
Market cap 1.18b 1.15b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack